RECOVERY Collaborative Group. 2023, 'Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial', The Lancet Diabetes & Endocrinology, 11(12), pp. 905-914. https://doi.org/10.1016/S2213-8587(23)00253-X